176 related articles for article (PubMed ID: 37371091)
1. The FAT1 Cadherin Drives Vascular Smooth Muscle Cell Migration.
Riascos-Bernal DF; Ressa G; Korrapati A; Sibinga NES
Cells; 2023 Jun; 12(12):. PubMed ID: 37371091
[TBL] [Abstract][Full Text] [Related]
2. Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.
Hou R; Sibinga NE
J Biol Chem; 2009 Mar; 284(11):6955-65. PubMed ID: 19131340
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
[TBL] [Abstract][Full Text] [Related]
4. The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals.
Hou R; Liu L; Anees S; Hiroyasu S; Sibinga NE
J Cell Biol; 2006 May; 173(3):417-29. PubMed ID: 16682528
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 suppresses vascular smooth muscle cell motility by expression of N-cadherin.
Nuessle JM; Giehl K; Herzog R; Stracke S; Menke A
Biol Chem; 2011 May; 392(5):461-74. PubMed ID: 21375457
[TBL] [Abstract][Full Text] [Related]
7. Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour.
George SJ; Beeching CA
Atherosclerosis; 2006 Sep; 188(1):1-11. PubMed ID: 16438974
[TBL] [Abstract][Full Text] [Related]
8. ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms.
Komatsu S; Ikebe M
Am J Physiol Heart Circ Physiol; 2014 May; 306(9):H1275-86. PubMed ID: 24633547
[TBL] [Abstract][Full Text] [Related]
9. Control of mitochondrial function and cell growth by the atypical cadherin Fat1.
Cao LL; Riascos-Bernal DF; Chinnasamy P; Dunaway CM; Hou R; Pujato MA; O'Rourke BP; Miskolci V; Guo L; Hodgson L; Fiser A; Sibinga NE
Nature; 2016 Nov; 539(7630):575-578. PubMed ID: 27828948
[TBL] [Abstract][Full Text] [Related]
10. The Atypical Cadherin FAT1 Limits Mitochondrial Respiration and Proliferation of Vascular Smooth Muscle Cells.
Riascos-Bernal DF; Maira A; Sibinga NES
Front Cardiovasc Med; 2022; 9():905717. PubMed ID: 35647082
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation.
Song P; Zhou Y; Coughlan KA; Dai X; Xu H; Viollet B; Zou MH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2800-9. PubMed ID: 24115035
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell in atherosclerosis.
Chistiakov DA; Orekhov AN; Bobryshev YV
Acta Physiol (Oxf); 2015 May; 214(1):33-50. PubMed ID: 25677529
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
14. Cadherins in vascular smooth muscle cell (patho)biology: Quid nos scimus?
Frismantiene A; Philippova M; Erne P; Resink TJ
Cell Signal; 2018 May; 45():23-42. PubMed ID: 29413845
[TBL] [Abstract][Full Text] [Related]
15. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation.
Xiao Q; Zhang F; Grassia G; Hu Y; Zhang Z; Xing Q; Yin X; Maddaluno M; Drung B; Schmidt B; Maffia P; Ialenti A; Mayr M; Xu Q; Ye S
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):90-8. PubMed ID: 24158518
[TBL] [Abstract][Full Text] [Related]
17. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
[TBL] [Abstract][Full Text] [Related]
18. Decreased Jagged1 expression in vascular smooth muscle cells delays endothelial regeneration in arteriovenous graft.
Guo Q; Huang F; Qing Y; Feng S; Xiao X; Wang Y; Liang M; Wang T; Mitch WE; Cheng J
Cardiovasc Res; 2020 Nov; 116(13):2142-2155. PubMed ID: 31913453
[TBL] [Abstract][Full Text] [Related]
19. miR‑19a promotes vascular smooth muscle cell proliferation, migration and invasion through regulation of Ras homolog family member B.
Sun G; Song H; Wu S
Int J Mol Med; 2019 Dec; 44(6):1991-2002. PubMed ID: 31573047
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
